BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 210 filers reported holding BRIDGEBIO PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $461,238 | +53.3% | 17,491 | 0.0% | 0.00% | +100.0% |
| Q2 2023 | $300,845 | +28.4% | 17,491 | +23.7% | 0.00% | 0.0% |
| Q1 2023 | $234,358 | +117.6% | 14,135 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $107,709 | +7.7% | 14,135 | +40.0% | 0.00% | 0.0% |
| Q3 2022 | $100,000 | +8.7% | 10,097 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $92,000 | -9.8% | 10,097 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $102,000 | -44.0% | 10,097 | -7.7% | 0.00% | 0.0% |
| Q4 2021 | $182,000 | -51.7% | 10,935 | +36.1% | 0.00% | -50.0% |
| Q3 2021 | $377,000 | -23.1% | 8,035 | -0.1% | 0.00% | -33.3% |
| Q2 2021 | $490,000 | +59.1% | 8,045 | +61.1% | 0.00% | +50.0% |
| Q1 2021 | $308,000 | – | 4,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $60,317,000 | 40.05% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $308,746,000 | 6.20% |
| M28 Capital Management LP | 513,300 | $5,102,000 | 5.33% |
| GREAT POINT PARTNERS LLC | 1,050,000 | $10,437,000 | 2.51% |
| Octagon Capital Advisors LP | 933,743 | $9,281,000 | 1.60% |
| HHLR ADVISORS, LTD. | 5,362,014 | $53,298,000 | 1.40% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $264,613,000 | 1.22% |
| Cormorant Asset Management, LP | 1,469,179 | $14,604,000 | 1.02% |
| Fernwood Investment Management, LLC | 204,550 | $2,033,000 | 0.86% |
| TANG CAPITAL MANAGEMENT LLC | 585,424 | $5,819,000 | 0.71% |